Drug Type Small molecule drug |
Synonyms MW 401, MW401 |
Target |
Action inverse agonists |
Mechanism GPR75 inverse agonists(G protein-coupled receptor 75 inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Kidney Diseases | Discovery | United States | 01 Jan 2026 | |
| Obesity | Discovery | United States | 01 Jan 2026 |





